STAT

NOVEMBER 26, 2024

New data from a mid-stage study of an Amgen obesity drug showed that it helped participants lose a substantial amount of weight, but questions about how competitive it could be appear to be shaping the response to the news, with the company’s share price falling on the announcement.  Amgen said Tuesday that that its drug, MariTide , led to an average of roughly 20% weight loss over a year in the Phase 2 study in participants who had obesity or who were overweight without type 2 diabe

133

133

PharmaVoice

NOVEMBER 26, 2024

Stoke Therapeutics is entering phase 3 with its RNA medicine designed to treat a rare epileptic condition.

278

278

Drug Topics

NOVEMBER 26, 2024

Jennifer Goldman, PharmD, CDCES, BC-ADM, FCCP, talks about the best ways pharmacists can stay updated on advancements in diabetes medications and treatments.

247

247

PharmaVoice

NOVEMBER 26, 2024

Pharma companies looking to get a break from the FTC under a new administration may be out of luck.

246

246

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

NOVEMBER 26, 2024

Researchers aimed to address the associations between gout and ischemic events, specifically ischemic colitis.

247

247

The Checkup by Singlecare

NOVEMBER 26, 2024

When you’re sick with a viral infection, you expect to feel poorly for a few days. COVID is no exception. Whether you’re hit with respiratory, GI, or flu-like symptoms such as muscle pain, headache, and fatigue, testing positive for COVID means being down for the count for a bit before returning to your daily routine. However, what if you don’t bounce back, even after you’re technically recovered?

Immunization 94

Immunization Hospitals FDA 94

DiversifyRx

NOVEMBER 26, 2024

Pharmacy cash flow is still struggling even though the DIR Fee Apocalypse is over. Read on to get 7 practical tips to improve your pharmacy’s cash flow. Pharmacy cash flow is the heartbeat of your business—it keeps the lights on, the shelves stocked, and your team paid. However, in today’s pharmacy landscape, cash flow challenges are more pressing than ever.

Independent Pharmacies 52

Independent Pharmacies 52

Drug Topics

NOVEMBER 26, 2024

Individuals who received tailored text message reminders about receiving a COVID-19 booster vaccine were more likely to get it.

Vaccines 190

Vaccines 190

Fierce Healthcare

NOVEMBER 26, 2024

Mount Sinai Health System has opened the doors of its new AI research center in Manhattan, the Hamilton and Amabel James Center for AI and Human Health. | Mount Sinai Health System announced on Tuesday that it opened its Hamilton and Amabel James Center for Artificial Intelligence and Human Health, which will be a research site for AI development.

133

133

Pharmacy Times

NOVEMBER 26, 2024

Pharmacists play a vital role in multidisciplinary health care teams by enhancing medication safety, optimizing therapeutic outcomes, expanding medication access, reducing costs, and improving patient education.

132

132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

NOVEMBER 26, 2024

Recursion Pharmaceuticals, one of the most advanced companies using artificial intelligence and machine learning tools to expedite drug development , laid off employees after closing a merger last week.

131

131

Fierce Healthcare

NOVEMBER 26, 2024

The Centers for Medicare & Medicaid Services (CMS) finalized a six-year mandatory model to increase access to kidney transplants, the agency announced Nov. 26. | CMS made some concessions to hospitals who strongly criticized the kidney transplant model proposed rule in May.

Hospitals 128

Hospitals 128

pharmaphorum

NOVEMBER 26, 2024

Discover the revolutionary impact of generative artificial intelligence (GenAI) on drug safety in pharmacovigilance. Learn how this cutting-edge technology is transforming the industry.

118

118

Fierce Healthcare

NOVEMBER 26, 2024

The Centers for Medicare & Medicaid Services (CMS) is attempting to cover anti-obesity medications under Medicare Part D and Medicaid, the agency announced Nov. 26. | With time running out before leaving office, the Biden administration is proposing a rule to have Medicare and Medicaid cover anti-obesity medications and bolster guardrails for AI, among the changes.

128

128

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

NOVEMBER 26, 2024

Moderna's missteps serve as a reminder of the importance of regulatory bodies like PMCPA in upholding ethics within the pharmaceutical industry. Learn more about their role and impact.

115

115

Fierce Healthcare

NOVEMBER 26, 2024

Providers are rapidly adopting generative AI-based clinical documentation tools to aid clinicians and make digital paperwork more efficient. | Cambridge Health Alliance, the only public academic health system in Massachusetts, is deploying Abridge's AI-based medical note-taking tool across its 600 clinicians after a successful pilot.

Documentation 124

Documentation 124

STAT

NOVEMBER 26, 2024

The new class of GLP-1 weight loss drugs have been blockbusters since they arrived on the market a few years ago. These medications have made tens of billions of dollars for drugmakers and have made their way into the public consciousness in a remarkable way.  Almost three-quarters of adults in the U.S. are overweight or obese, and obesity can lead to a litany of health complications, including heart disease, joint pain, and cancer.

FDA 112

FDA 112

Pharmacy Times

NOVEMBER 26, 2024

Investigators also found that vaccination for those aged 27 to 45 produces a higher number needed to vaccinate.

Vaccines 111

Vaccines 111

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

NOVEMBER 26, 2024

Outgoing US President Joe Biden has proposed a dramatic expansion of Medicare coverage of obesity drugs, but will the plan see the light of day?

111

111

STAT

NOVEMBER 26, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Happy Tuesday! Adam Feuerstein, here, filling in for your regular Readout correspondents.

105

105

pharmaphorum

NOVEMBER 26, 2024

Medigene slashes staff and delays trials of its lead TCR therapy candidate as it refocuses its pipeline.

111

111

Pharmaceutical Technology

NOVEMBER 26, 2024

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration agreement to investigate the vaccine.

Vaccines 98

Vaccines 98

pharmaphorum

NOVEMBER 26, 2024

Roche has upgraded its partnership with off-the-shelf CAR-T therapy specialist Poseida to a $1 billion-plus takeover bid.

98

98

Fierce Healthcare

NOVEMBER 26, 2024

Pittsburgh-based health insurer and provider Highmark Health has brought in $529 million in net income through the first three quarters of the year, according to its latest financial details releas | Highmark Health has brought in $529 million in net income through the first three quarters of the year, according to its latest financial details.

Insurance 93

Insurance 93

pharmaphorum

NOVEMBER 26, 2024

ZENITH trial of MSD's Winrevair in PAH could add further momentum to an already impressive launch.

97

97

Fierce Healthcare

NOVEMBER 26, 2024

Providence was on track for its first positive operating year since the pandemic through the first six months of 2024, but a $208 million operating loss in the third quarter dragged down its perfor | Providence was on track for its first positive operating year since the pandemic through the first six months of 2024, but a $208 million operating loss in the third quarter dragged down its performance.

92

92

Fierce Pharma

NOVEMBER 26, 2024

In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of “am | Shorla Oncology has scored an FDA approval for its strawberry-flavored drink version of Novartis' cancer drug Gleevec. Dubbed Imkeldi, it becomes the first oral liquid form of imatinib.

FDA 84

FDA 84

pharmaphorum

NOVEMBER 26, 2024

Cassava Sciences' troubled development of Alzheimer's disease candidate simufilam looks like it may have finally reached the end

81

81

Pharmacy Times

NOVEMBER 26, 2024

Exposure to pollutants PM2.5 and NO2 was found to increase the likelihood of developing a peanut allergy and of the allergy persisting.

73

73

Pharmaceutical Technology

NOVEMBER 26, 2024

PCI Pharma Services is a winner in the Innovation and Business Expansion categories in the 2024 Pharmaceutical Technology Excellence Awards.

59

59

Pharmacy Times

NOVEMBER 26, 2024

Augmentation is a condition in which RLS symptoms intensify or change in response to long-term dopamine agonist treatment.

62

62

Compounding Pharmacy of America

NOVEMBER 26, 2024

Learn about the benefits, types, and effectiveness of topical pain relief, including custom compounded gels. Discover how personalized topical solutions can target pain efficiently. The post A Complete Guide to Topical Pain Relief: Benefits, Types, and Customized Solutions appeared first on The Compounding Pharmacy of America.

Compounding Pharmacies 52

Compounding Pharmacies Compounding 52

PharmExec

NOVEMBER 26, 2024

Results of the RESILIENT SMA study found that while taldefgrobep demonstrated clinically meaningful motor function improvements in patients with spinal muscular atrophy, the treatment arm did not achieve statistical significance at 48 weeks.

52

52